2024    2023    2022    2021    2020    2019    2018    2017    2016   

2021

Articles

341 - 

Occupational Exposures to Organic Solvents and Asthma Symptoms in the CONSTANCES Cohort

Guillaume Sit, Noemie Letellier, Yuriko Iwatsubo, Marcel Goldberg, Bénédicte Leynaert et al.

International Journal of Environmental Research and Public Health, 2021, 18 (17), pp.9258.

DOI : https://doi.org/10.3390/ijerph18179258

Pubmed : 34501848

 

342 - 

Towards a reduced in silico model predicting biochemical recurrence after radiotherapy in prostate cancer

Carlos Sosa-Marrero, Renaud de Crevoisier, Alfredo Hernandez, Pierre Fontaine, Nathalie Rioux-Leclercq et al.

IEEE Transactions on Biomedical Engineering, 2021, 68 (9), pp.2718-2729.

DOI : https://doi.org/10.1109/TBME.2021.3052345

Pubmed : 33460366

 

343 - 

Les microARN circulants comme bioindicateurs d’exposition aux HAP seuls et en mélange

Lydie Sparfel

Les microARN circulants comme bioindicateurs d’exposition aux HAP seuls et en mélange : Utilisation des MiARN circulants comme indicateurs d’exposition aux hydrocarbures aromatiques polycycliques seuls et en mélange. Les cahiers de la Recherche : Santé, Environnement, Travail, 2021, Les contaminants chimiques seuls ou en mélange, 16, pp.46-48.

 

344 - 

Roles of Rrp6/EXOSC10-targeted lncRNAs in anti-cancer drug toxicity and cell wall architecture

I. Stuparevic, A. Novacic, M. Oskomic, L. Strbac, V. Beauvais et al.

FEBS Open Bio, 2021, 11 (S1), pp.102-102.

DOI : https://doi.org/10.1002/2211-5463.13206

Pubmed : 34212521

 

345 - 

Regulation of the conserved 3 '-5 ' exoribonuclease EXOSC10/Rrp6 during cell division, development and cancer

Igor Stuparevic, Ana Novacic, A.R. Rahmouni, Anne Fernandez, Ned J. Lamb et al.

Biological Reviews, 2021, 96 (4), pp.1092-1113.

DOI : https://doi.org/10.1111/brv.12693

Pubmed : 33599082

 

346 - 

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade

Stéphane Terry, Cécile Dalban, Nathalie Rioux-Leclercq, Julien Adam, Maxime Meylan et al.

Clinical Cancer Research, 2021, 27 (24), pp.6749-60.

DOI : https://doi.org/10.1158/1078-0432.CCR-21-0972

Pubmed : 34407968

 

347 - 

Radiogenomics in prostate cancer evaluation

Ronan Thenault, Anis Gasmi, Zine-Edine Khene, Karim Bensalah, Romain Mathieu et al.

Current Opinion in Urology, 2021, 31 (4), pp.424-429.

DOI : https://doi.org/10.1097/MOU.0000000000000902

Pubmed : 34009176

 

348 - 

ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment

Nathalie Theret, Fidaa Bouezzeddine, Fida Azar, Mona Diab-Assaf, Vincent Legagneux et al.

Cancers, 2021, 13 (7), pp.1563.

DOI : https://doi.org/10.3390/cancers13071563

Pubmed : 33805340

 

349 - 

Editorial: HBV cure-the quest for biomarkers to predict off-treatment sustained response

Vincent Thibault, Tarik Asselah

Alimentary Pharmacology and Therapeuthics, 2021, 53 (4), pp.552-554.

DOI : https://doi.org/10.1111/apt.16214

Pubmed : 33616973

 

350 - 

Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation

Benjamin Thoreau, Florent von Tokarski, Adeline Bauvois, Guillaume Bayer, Christelle Barbet et al.

Clinical Journal of the American Society of Nephrology, 2021, 16 (9), pp.1355-1364.

DOI : https://doi.org/10.2215/CJN.17511120

Pubmed : 34497111